698. In vitro Activity of a New Generation Oxopyrazole Antibiotic Against Multidrug-Resistant Gram-Negative Bacilli

BACKGROUND: Multidrug-resistant Gram-negative bacilli (MDRGNB) are emerging as a challenging cause of hospital-acquired infections and represent a critical need for innovative antibacterial development. New oxopyrazole agents targeting penicillin-binding proteins (PBPs) based on a non-β-lactam core...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldberg, Joel, Bethel, Christopher, Hujer, Andrea M, Hujer, Kristine, Marshall, Steven, Papp-Wallace, Krisztina M, Perez, Federico, Spencer, Elizabeth, Hoyer, Denton, Plummer, Mark, Bonomo, Robert A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811137/
http://dx.doi.org/10.1093/ofid/ofz360.766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811137/
http://dx.doi.org/10.1093/ofid/ofz360.766

Ejemplares similares